Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 medications including tirzepatide and semaglutide slow gastric emptying—the rate at which food and medications move through your stomach—which can interfere with how your body absorbs oral contraceptives. If you're considering weight loss treatment and rely on birth control pills, understanding this interaction is essential for maintaining reliable contraception.
How GLP-1 Medications Affect Oral Contraceptive Absorption
GLP-1 receptor agonists work by slowing gastric motility, which is the stomach's ability to contract and move contents into the small intestine. This mechanism reduces appetite and helps with weight loss, but it also means medications—including birth control pills—stay in your stomach longer before absorption occurs. When a pill spends more time in the stomach and moves slowly through your digestive tract, your body may absorb less of the active hormone, potentially reducing its contraceptive effect.
The degree of reduced absorption varies among individuals based on genetics, stomach acid levels, and how quickly your specific body metabolizes hormones. Research on GLP-1 agents has documented delayed gastric emptying in clinical trials, though studies specifically measuring contraceptive failure rates remain limited. This is why your healthcare provider should review your current birth control method before you start tirzepatide, semaglutide, or any GLP-1 therapy.
Birth Control Method Options During GLP-1 Weight Loss Treatment
Non-oral contraceptive methods are generally preferred during GLP-1 therapy because they bypass the digestive system entirely. Long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and subdermal implants deliver hormones directly into your bloodstream or prevent fertilization mechanically, making them unaffected by gastric changes. Barrier methods like condoms, diaphragms, and cervical caps also remain reliable choices and carry no absorption risk.
If you prefer to continue oral contraceptives, your doctor may recommend taking your pill at a different time than your GLP-1 injection, or switching to a higher-dose formulation to compensate for potential reduced absorption. Transdermal patches and vaginal rings bypass oral absorption too, offering another hormone-delivery alternative. The key is having an explicit conversation with your healthcare provider about your contraception plan before starting weight loss medication.
Timing Your Medications and Backup Contraception Strategy
If you decide to stay on oral birth control while using GLP-1 therapy, spacing out the timing of your pill and your weekly injection may help. Taking your contraceptive pill at a time when your stomach is emptying more predictably—typically earlier in the day or on an empty stomach—could improve absorption, though research hasn't definitively established optimal spacing. Many clinicians suggest using backup contraception (such as condoms) for at least the first one to two months of GLP-1 treatment while your body adjusts.
Backup contraception becomes especially important if you experience nausea, vomiting, or other gastrointestinal side effects common during the first weeks of GLP-1 therapy, since these symptoms further reduce pill absorption. If you vomit shortly after taking your contraceptive pill, follow your birth control package instructions regarding backup methods. PlexusDx patients should discuss their specific medication timing with their healthcare provider to create a personalized plan that addresses both weight loss and contraceptive reliability.
Genetic Factors in Hormone Metabolism and Contraceptive Response
Your body's ability to metabolize hormones—both from birth control and from GLP-1 medications—is partly determined by genetic variation. The PlexusDx Precision Peptide Genetic Test identifies key variants in metabolic pathways that influence how your body processes peptide-based medications and certain hormonal compounds. Understanding your individual genetic profile helps your provider predict whether you might experience faster or slower GLP-1 effects, which indirectly affects how your gastric changes may impact contraceptive absorption.
Certain genetic variations in genes controlling liver metabolism can make some people process hormonal medications more slowly, meaning reduced gastric emptying from GLP-1 therapy could create a compounding effect on pill absorption. Conversely, individuals with variants that speed up hormone metabolism may maintain better contraceptive levels despite delayed gastric transit. This personalized insight empowers your healthcare team to recommend the most reliable contraception strategy tailored to your unique biology.
Starting Tirzepatide or Semaglutide: Contraception Planning Checklist
Before you begin compounded tirzepatide injection or semaglutide therapy at PlexusDx, create a contraception plan with your prescribing provider. Gather information about your current birth control method, how long you've used it, any past absorption issues, and whether you've experienced breakthrough bleeding or other signs of inconsistent hormone levels. Review whether switching to a non-oral method is realistic for your lifestyle, or whether adjusting timing and backup methods makes more sense.
PlexusDx's tirzepatide injection starts at $249 per month and serves all 50 states without requiring insurance, making weight loss treatment accessible to many people simultaneously managing contraception. When you have your initial consultation, be explicit about your contraceptive needs so your healthcare provider can factor that into your medication choice—whether oral tirzepatide, compounded injection tirzepatide, semaglutide, or one of PlexusDx's combination protocols. Documenting this conversation ensures accountability and creates a safety net for unintended pregnancy prevention during your weight loss journey.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I get pregnant if I take birth control pills while on GLP-1 medication?
GLP-1 medications can reduce oral contraceptive absorption, increasing pregnancy risk if you rely solely on pills without backup methods. Discuss alternative contraception or backup strategies with your provider before starting therapy. If you're already taking both, use condoms or other backup methods for the first 1–2 months while your digestive system adjusts.
What birth control methods are safest during tirzepatide therapy?
Long-acting reversible contraceptives like IUDs and implants, barrier methods like condoms, and transdermal patches or vaginal rings are unaffected by gastric changes from GLP-1 medications. If you prefer oral pills, discuss spacing strategies and backup methods with your provider. PlexusDx tirzepatide patients should raise this topic during their initial consultation.
Does PlexusDx provide guidance on contraception while using their medications?
PlexusDx's clinical team will discuss medication interactions including contraception during your consultation. While PlexusDx prescribers cannot replace your gynecologist, they factor contraception into your overall treatment plan. Always inform both your GYN and weight loss provider about all medications to ensure comprehensive safety management.
How long does GLP-1 slow gastric emptying, and when is birth control absorption normal again?
Gastric slowing persists as long as you take GLP-1 medication and gradually reverses after discontinuation. Full gastric function typically returns within 1–2 weeks of stopping tirzepatide or semaglutide. If you plan to stop GLP-1 therapy, discuss adjusting contraception timing with your provider beforehand.
Can the PlexusDx Precision Peptide Genetic Test predict my contraceptive response?
The Precision Peptide Genetic Test ($99 add-on after first month) maps 14 pathways and identifies variants in hormone metabolism genes that influence how your body processes medications. While not a direct contraceptive prediction tool, it reveals genetic insights that help your provider choose the safest contraception method alongside your GLP-1 therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Who Should Take Wegovy for Weight Loss?
Navigating Your Wellness Journey: Can I Take Ozempic After Liposuction?